162 related articles for article (PubMed ID: 36749488)
1. Neuromuscular Junction-on-a-Chip for Amyotrophic Lateral Sclerosis Modeling.
Alavi-Moghadam S; Kokabi-Hamidpour S; Rezaei-Tavirani M; Larijani B; Arjmand R; Rahim F; Rezazadeh-Mafi A; Adibi H; Arjmand B
Methods Mol Biol; 2024; 2736():139-150. PubMed ID: 36749488
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular junction-on-a-chip: ALS disease modeling and read-out development in microfluidic devices.
de Jongh R; Spijkers XM; Pasteuning-Vuhman S; Vulto P; Pasterkamp RJ
J Neurochem; 2021 May; 157(3):393-412. PubMed ID: 33382092
[TBL] [Abstract][Full Text] [Related]
3. Organ on a Chip: A Novel
Arjmand B; Kokabi Hamidpour S; Rabbani Z; Tayanloo-Beik A; Rahim F; Aghayan HR; Larijani B
Front Neurol; 2021; 12():788462. PubMed ID: 35111126
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular disease modeling on a chip.
Santoso JW; McCain ML
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32817118
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
[TBL] [Abstract][Full Text] [Related]
6. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).
Alhindi A; Boehm I; Chaytow H
J Anat; 2022 Nov; 241(5):1089-1107. PubMed ID: 34101196
[TBL] [Abstract][Full Text] [Related]
7. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons.
Osaki T; Uzel SGM; Kamm RD
Sci Adv; 2018 Oct; 4(10):eaat5847. PubMed ID: 30324134
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
[TBL] [Abstract][Full Text] [Related]
9. New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.
Arbour D; Vande Velde C; Robitaille R
J Physiol; 2017 Feb; 595(3):647-661. PubMed ID: 27633977
[TBL] [Abstract][Full Text] [Related]
10. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.
Lépine S; Castellanos-Montiel MJ; Durcan TM
Transl Neurodegener; 2022 Dec; 11(1):56. PubMed ID: 36575535
[TBL] [Abstract][Full Text] [Related]
12. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction.
Appel SH; Engelhardt JI; García J; Stefani E
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):647-51. PubMed ID: 1988960
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Kinases in Amyotrophic Lateral Sclerosis at the Neuromuscular Synapse: Insights into BDNF/TrkB and PKC Signaling.
Lanuza MA; Just-Borràs L; Hurtado E; Cilleros-Mañé V; Tomàs M; Garcia N; Tomàs J
Cells; 2019 Dec; 8(12):. PubMed ID: 31817487
[TBL] [Abstract][Full Text] [Related]
15. How to Build and to Protect the Neuromuscular Junction: The Role of the Glial Cell Line-Derived Neurotrophic Factor.
Stanga S; Boido M; Kienlen-Campard P
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374485
[TBL] [Abstract][Full Text] [Related]
16. Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis.
Li L; Liu J; She H
CNS Neurol Disord Drug Targets; 2019; 18(5):366-371. PubMed ID: 30963986
[TBL] [Abstract][Full Text] [Related]
17. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
18. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
19. Wheel Running Adversely Affects Disease Onset and Neuromuscular Interplay in Amyotrophic Lateral Sclerosis Slow Progression Mouse Model.
Golini E; Marinelli S; Pisu S; De Angelis F; Vacca V; Rava A; Casola I; Laurenzi G; Rizzuto E; Giuliani A; Musarò A; Dobrowolny G; Mandillo S
Curr Neurovasc Res; 2023; 20(3):362-376. PubMed ID: 37614106
[TBL] [Abstract][Full Text] [Related]
20. Current Progress in the Creation, Characterization, and Application of Human Stem Cell-derived in Vitro Neuromuscular Junction Models.
Lynch E; Peek E; Reilly M; FitzGibbons C; Robertson S; Suzuki M
Stem Cell Rev Rep; 2022 Feb; 18(2):768-780. PubMed ID: 34212303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
